Concepedia

Marybeth Sechler

MS

Statistics

Publications

8

Citations

320

H-Index

8

Active since

2012

Affiliations

University of Colorado Anschutz Medical Campus(Current)

University of Colorado Denver

University of Colorado Cancer Center

Veterans Health Administration

University of Illinois Chicago

Marybeth Sechler is an author at University of Colorado Anschutz Medical Campus specializing in oncology, molecular oncology, and molecular biology.

Publications per year

2012–2020

8

Publications

8

The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in Ewing Sarcoma

Janet K. Parrish, Marybeth Sechler, R A Winn et al. · Oncogene · 2013 · 83 citations

Life Sciences, Genetics, Molecular Biology +14

The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing Sarcoma cell migration and metastasis

Marybeth Sechler, Janet K. Parrish, Diane K. Birks et al. · Oncogene · 2017 · 69 citations · Full text

Medicine, Molecular Biology, Oncology +15

The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth

Janet K. Parrish, Tyler McCann, Marybeth Sechler et al. · Oncotarget · 2018 · 54 citations · Full text

Medicine, Cancer Biology, Oncology +17

Dishevelled3 is a novel arginine methyl transferase substrate

Rama Kamesh Bikkavilli, Sreedevi Avasarala, Michelle Van Scoyk et al. · Scientific Reports · 2012 · 40 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +17

Novel Role for γ-Catenin in the Regulation of Cancer Cell Migration via the Induction of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1)

Marybeth Sechler, Stanley Borowicz, Michelle Van Scoyk et al. · Journal of Biological Chemistry · 2015 · 25 citations · Full text

Medicine, Cell Biology, Oncology +12

1–5 of 8